Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Villeneuve, A.
1979.
Neuropsychopharmacology.
p.
187.
Pinder, Roger M.
1979.
Annual Reports in Medicinal Chemistry Volume 14.
Vol. 14,
Issue. ,
p.
1.
Souto, Mario
Francès, Henriette
Lecrubier, Yves
Puech, Alain J.
and
Simon, Pierre
1979.
Antagonism by d,1-propranolol of imipramine effects in mice.
European Journal of Pharmacology,
Vol. 60,
Issue. 1,
p.
105.
Hall, Håkan
Sällemark, Maria
and
Ross, Svante B.
1980.
Clenbuterol, a Central β‐Adrenoceptor Agonist.
Acta Pharmacologica et Toxicologica,
Vol. 47,
Issue. 2,
p.
159.
van Praag, H.M.
1980.
Central monoamine metabolism in depressions. II. Catecholamines and related compounds.
Comprehensive Psychiatry,
Vol. 21,
Issue. 1,
p.
44.
Hallberg, Hel�ne
Almgren, O.
and
Svensson, T. H.
1980.
Reduced brain monoamine synthesis by systemic treatment with terbutaline, a ?2-receptor agonist.
Journal of Neural Transmission,
Vol. 48,
Issue. 3,
p.
167.
Lecrubier, Y.
Puech, A. J.
Jouvent, R.
Simon, P.
and
Widlocher, D.
1980.
A Beta Adrenergic Stimulant (Salbutamol) versus Clomipramine in Depression: A Controlled Study.
British Journal of Psychiatry,
Vol. 136,
Issue. 4,
p.
354.
Hallberg, Heléne
Almgren, Olle
and
Svensson, Torgny H.
1980.
Centralnervösa effekter av beta-2-receptoragonisten salbutamol — ett potentiellt antidepressivt läkemedel?.
Nordisk Psykiatrisk Tidsskrift,
Vol. 34,
Issue. 6,
p.
561.
Wirz-Justice, Anna
Arendt, Josephine
and
Marston, Anne
1980.
Antidepressant drugs elevate rat pineal and plasma melatonin.
Experientia,
Vol. 36,
Issue. 4,
p.
442.
Belmaker, R.H.
Lerer, B.
and
Ebstein, R.P.
1981.
Recent Advances in Neuropsycho-Pharmacology.
p.
17.
Hallberg, Hel�ne
Almgren, Olle
and
Svensson, Torgny H.
1981.
Increased brain serotonergic and noradrenergic activity after repeated systemic administration of the beta-2 adrenoceptor agonist salbutamol, a putative antidepressant drug.
Psychopharmacology,
Vol. 73,
Issue. 3,
p.
201.
Lerer, B.
Ebstein, R. P.
and
Belmaker, R. H.
1981.
Subsensitivity of human ?-adrenergic adenylate cyclase after salbutamol treatment of depression.
Psychopharmacology,
Vol. 75,
Issue. 2,
p.
169.
Prichard, B. N. C.
Owens, C. W. I.
and
Tuckman, J.
1981.
Adrenergic Activators and Inhibitors.
Vol. 54 / 2,
Issue. ,
p.
559.
Hollister, Leo E.
1981.
‘Second generation’ antidepressant drugs.
Psychosomatics,
Vol. 22,
Issue. 10,
p.
872.
Svensson, T. H.
Dahlöf, C.
Engberg, G.
and
Hallberg, H.
1981.
Central pre‐ and postsynaptic monoamine receptors in antidepressant therapy.
Acta Psychiatrica Scandinavica,
Vol. 63,
Issue. s290,
p.
67.
PRATT, HELENOR F.
1982.
Abuse of salbutamol inhalers in young people.
Clinical & Experimental Allergy,
Vol. 12,
Issue. 2,
p.
203.
Hallberg, Hel�ne
Almgren, Olle
and
Svensson, Torgny H.
1982.
Reduced brain serotonergic activity after repeated treatment with ?-adrenoceptor antagonists.
Psychopharmacology,
Vol. 76,
Issue. 2,
p.
114.
Vardi, Y.
Regev, I.
Rosenbaum, M.
and
Flechter, S.
1983.
The behavioral effect of salbutamol (a beta-adrenergic receptor stimulant) on reserpine- and propranolol-treated rats.
Journal of Neurology,
Vol. 230,
Issue. 1,
p.
43.
Lerer, Bernard
and
Sitaram, Natraj
1983.
Clinical strategies for evaluating ect mechanisms — pharmacological, biochemical and psychophysiological approaches.
Progress in Neuro-Psychopharmacology and Biological Psychiatry,
Vol. 7,
Issue. 2-3,
p.
309.
Frances, Henriette
Puech, Alain J.
Danti, Sabine
and
Simon, Pierre
1983.
Attempt at pharmacological differentiation of central β-adrenergic receptors.
European Journal of Pharmacology,
Vol. 92,
Issue. 3-4,
p.
223.